Mark Evans

Mark Evans is an entrepreneurial executive with a finance background and extensive general management experience in the technology industry, including roles in 3 tech start-ups.

His sector expertise lies in high-tech (hardware and software), nanotech/semiconductor, healthcare/medtech (In-vitro Diagnostics, Medical Imaging, PET Biomarkers), and cyber security.

Mark has been actively involved in various industry advisory groups and councils, such as the UK's Precision Medicine Catapult and the Oxford Academic Health Science Network.

He has been a mentor and lecturer on prestigious programs like the Goldman Sachs '10,000 Small Business program' and the Chevening Rolls-Royce Science and Innovation Leadership Programme at Oxford University.

His educational background includes a Venture Capital Executive Program from the University of California, Berkeley, a BA in Business Studies from the University of Stirling, and an MBA from the University of Oxford - Said Business School.

Mark Evans has held key positions in several organizations, including Founder and CEO at Adaptix Ltd, and various roles at companies like Cydar, InsurTechnix, and Oxford nanoSystems Ltd.

His previous roles include CFO at Secerno, Co-Founder and Chairman at Mirada Medical, Vice President at Siemens Medical Solutions Diagnostics, and finance leadership positions at companies like Swisscom Eurospot UK, Siemens Molecular Imaging Ltd, and Bell Microproducts.

Mark has a strong background in finance and general management, with a focus on the technology sector, making him a valuable asset in the entrepreneurial and start-up ecosystem.